Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Par Drugs and Chemicals Ltd

Your Vote -

Buy

78.95%

Hold

5.26%

Sell

15.79%

78.95%

19 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

187.57

82

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

82

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Par Drugs and Chemicals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Par Drugs & Chemical - Copy of Newspaper Publication

    9 May 2025, 3:12PM Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
  • Par Drugs & Chemical Q4 net profit down 55.65% at Rs 1.65 cr

    8 May 2025, 9:10PM The company reported standalone net profit of Rs 1.65 crore for the quarter ended March 31, 2025 as compared to Rs 3.72 crore in the same period last
  • Par Drugs & Chemical - Updates

    8 May 2025, 7:37PM Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting 08.05.2025'.
  • Par Drugs & Chemical - Outcome of Board Meeting

    8 May 2025, 7:33PM Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 08, 2025.
  • Par Drugs & Chemical - Outcome of Board Meeting

    8 May 2025, 7:30PM Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on May 08, 2025.
  • Par Drugs & Chemical - Outcome of Board Meeting

    8 May 2025, 7:27PM Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 08, 2025.
  • Par Drugs & Chemical - General Updates

    6 May 2025, 12:26PM Par Drugs And Chemicals Limited has informed the Exchange about General Updates
  • Par Drugs & Chemical - Board Meeting Intimation

    26 Apr 2025, 11:13AM PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-May-2025 to consider and approve the Yearly Audited Fin
  • Par Drugs & Chemical - Structural Digital Database

    21 Apr 2025, 4:32PM Compliance Certificate of Structural Digital Database under SEBI (PIT) Regulations, 2015 for the F.Y. 2024-25 ended on 31.03.2025 (for whole year)
  • Par Drugs & Chemical has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    19 Apr 2025, 7:00AM As of March 2025, 73.37% is owned by Indian Promoters and 26.63% by Public. <p align=justify> Top five Promoters holding highest number of shares of P
  • Par Drugs & Chemical - Updates

    18 Apr 2025, 6:06PM Par Drugs And Chemicals Limited has informed the Exchange regarding 'Intimation of Update in Contact details of RTA of Company.'.
  • Par Drugs & Chemical - Disclosure under SEBI Takeover Regulations

    15 Apr 2025, 1:12PM Mr. Jignesh V. Savani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substan
  • Par Drugs & Chemical - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Apr 2025, 11:02AM Par Drugs And Chemicals Limited has informed the Exchange about Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulation
  • Par Drugs & Chemical - Updates

    29 Mar 2025, 12:35PM Par Drugs And Chemicals Limited has informed the Exchange regarding 'update'.
  • Par Drugs & Chemical - Trading Window-XBRL

    26 Mar 2025, 12:11PM PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Closure of Trading Window
  • Par Drugs & Chemical - Trading Window

    26 Mar 2025, 12:10PM Par Drugs And Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regul

Key fundamentals

Evaluate the intrinsic value of Par Drugs and Chemicals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 98.9749 85.632 71.2383 59.8772 59.8542
Liabilities 98.9749 85.632 71.2383 59.8772 59.8542
Equity 12.3046 12.3046 12.3046 12.3046 6.1523
Gross Profit 19.5013 22.8175 18.2073 16.2547 16.0127
Net Profit 13.3579 14.501 11.3341 9.2133 11.6112
Cash From Operating Activities 16.1602 20.2489 13.377 7.6152 12.085
NPM(%) 13.22 15.16 11.83 12.27 19.11
Revenue 100.9735 95.6404 95.7488 75.0744 60.7513
Expenses 81.4722 72.8229 77.5415 58.8197 44.7385
ROE(%) 13.8 14.98 11.71 9.52 11.99

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
10 Jul 2020 1.25 12.5 0 35

Peers

Other companies within the same industry or sector that are comparable to Par Drugs and Chemicals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 860.50 1.12 28.55 0.00 301.39 0.58
Lotus Eye Hospital and Institute Ltd 73.81 0.44 210.89 0.00 3.55 0.00
Vaishali Pharma Ltd 12.99 0.93 216.50 0.00 3.13 0.00
Astec Lifesciences Ltd 814.35 0.37 0.00 0.00 -687.10 0.00

Company Info

The Company was originally incorporated as "Par Drugs and Chemicals Private Limited" at Bhavnagar, Gujarat as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated February 26, 1999 bearing Registration Number 04-35512 of 1998-99 issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli. Subsequently, the Company was converted into a Public Limited Company pursuant to special resolution passed by the members in Extra-ordinary General Meeting of the Company held on October 24, 2018 and the name of the Company was changed to "Par Drugs and Chemicals Limited" and a fresh certificate of incorporation consequent upon Conversion of Private Company to Public Limited dated November 5, 2018 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24117GJ1999PLC035512.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY1999- Incorporated as a Private Limited Company with the name `Par Drugs and Chemicals Private Limited'1999- Acquisition of the ongoing business of the M/s. Par In Organic2018- Conversion of the Company from Private Limited to Public Limited 2018 -Company converted from Private Limited to Limited. 2019 -The Company has successfully come up with an Initial Public Offer (IPO) of 16,72,000 Equity Shares of face value of 10 each. 2021 -The Company has issued Bonus Shares in the Ratio of 1:1.

The Company was originally incorporated as "Par Drugs and Chemicals Private Limited" at Bhavnagar, Gujarat as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated February 26, 1999 bearing Registration Number 04-35512 of 1998-99 issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli. Subsequently, the Company was converted into a Public Limited Company pursuant to special resolution passed by the members in Extra-ordinary General Meeting of the Company held on October 24, 2018 and the name of the Company was changed to "Par Drugs and Chemicals Limited" and a fresh certificate of incorporation consequent upon Conversion of Private Company to Public Limited dated November 5, 2018 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24117GJ1999PLC035512.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY1999- Incorporated as a Private Limited Company with the name `Par Drugs and Chemicals Private Limited'1999- Acquisition of the ongoing business of the M/s. Par In Organic2018- Conversion of the Company from Private Limited to Public Limited 2018 -Company converted from Private Limited to Limited. 2019 -The Company has successfully come up with an Initial Public Offer (IPO) of 16,72,000 Equity Shares of face value of 10 each. 2021 -The Company has issued Bonus Shares in the Ratio of 1:1.

Read More

Parent Organisation

Par Drugs & Chemicals Ltd.

Founded

26/02/1999

Managing Director

Mr.Jignesh Vallabhbhai Savani

NSE Symbol

PARBE

FAQ

The current price of Par Drugs and Chemicals Ltd is

The 52-week high for Par Drugs and Chemicals Ltd is

The market capitalization of Par Drugs and Chemicals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Par Drugs and Chemicals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Par Drugs and Chemicals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Par Drugs and Chemicals Ltd shares.

The CEO of Par Drugs and Chemicals Ltd is Mr.Jignesh Vallabhbhai Savani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT